The Valley Desk

NCT02689726 · Interventional trial

Safety, Tolerability, and Immunogenicity of GTL001 Vaccine Adjuvanted With Imiquimod Cream in HPV 16- and/or HPV 18-Infected Women Aged 25 to 65 Years, With Normal Cytology, ASCUS, or LSIL

Overall registry status Terminated

Phase 1

Conditions HPV 16- and/or HPV 18-Infected Women With Normal Cytology, ASCUS, or LSIL

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov